Halozyme Therapeutics Inc...

NASDAQ: HALO · Real-Time Price · USD
67.28
1.74 (2.65%)
At close: Aug 15, 2025, 3:59 PM
67.50
0.33%
After-hours: Aug 15, 2025, 07:58 PM EDT

Halozyme Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
165.16M 118.09M 137.01M 137.01M 93.25M 76.82M 85.39M 81.84M 74.75M 39.62M 57.7M 61.63M 22.68M 60.11M 66.77M 216.59M 91.46M 27.89M
Depreciation & Amortization
20.5M 20.45M 20.41M 20.36M 20.36M 20.21M 20.69M 23.08M 20.63M 20.46M 7.11M 29.2M 12.55M 778K 773K 751K 735K 738K
Stock-Based Compensation
12.16M 10.67M 11.46M 12.58M 9.47M 9.87M 9.66M 9.37M 9.62M 7.97M 7.22M 6.8M 5.63M 4.74M 5.13M 5.4M 5.37M 4.92M
Other Working Capital
n/a 4.22M 55.81M 37.18M -42.24M 23.48M -22.14M -10.4M 4.87M -4.93M 10.41M -5.04M 5.86M -9.17M -2.74M -3.19M 3.34M -2.33M
Other Non-Cash Items
-83.55M 390K -499K -926K 90.95M 51.89M 3.28M -13.66M -1.19M 1.24M 817K 5.9M 2.26M 910K 1.03M 283K 284K 21.5M
Deferred Income Tax
-7.09M -2.86M -15.29M 292K 14.24M 1.29M 9.42M 9.7M 11.51M 3.87M 14.68M 25.7M -13.3M 12.93M -12.95M -141.91M 594K 351K
Change in Working Capital
-7.47M 7.47M 25.37M -53.94M -82.26M 21.55M -26.1M 22.09M -48.48M 13.81M -5.08M -59.6M 10.39M -31.67M 21.77M 40.63M -61.55M 2.89M
Operating Cash Flow
99.71M 154.22M 178.47M 115.38M 55.79M 129.43M 102.35M 132.41M 66.84M 86.96M 82.45M 69.64M 40.23M 47.8M 82.52M 121.74M 36.89M 58.3M
Capital Expenditures
-1.56M -950K -3.05M -1.52M -2.58M -3.54M -2.6M -2.94M 1.62M -11.38M -2.34M -1.01M -968K -490K -158K -496K -533K -270K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a 5.7M 80.51M n/a 48.78M 9.98M n/a -999.12M n/a n/a n/a n/a n/a
Purchase of Investments
-102.76M -139.64M -51.44M -303.97M -93.42M -198.76M -21.29M -161.7M n/a -109.92M -29.52M n/a -40.87M -184.81M -369.16M -41.43M -120.95M -120.98M
Sales Maturities Of Investments
189.11M 50.17M 83.98M 138.01M 53.96M 119.63M 15.6M 81.19M 53.37M 61.13M 20.13M n/a 590M 136M 69.85M 24.97M 76.86M 76M
Other Investing Acitivies
n/a n/a n/a n/a -39.46M -79.14M -5.7M -80.51M 53.37M -48.78M 9.98M n/a 16.02M -48.81M -299.31M -16.46M -44.08M -44.98M
Investing Cash Flow
84.79M -90.42M 29.48M -167.48M -42.04M -82.68M -8.29M -83.45M 54.99M -60.16M -1.75M -1.01M -434.95M -49.3M -299.47M -16.95M -44.62M -45.25M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a -13.48M n/a 184.97M 364M n/a n/a n/a n/a 415.81M
Common Stock Repurchased
-303.49M n/a -250M n/a n/a -489K -252.3M n/a 1.05M -150.08M -1K -200M n/a n/a -160.32M -64.72M -48.84M -76.18M
Dividend Paid
n/a n/a n/a n/a n/a n/a -13.48M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
3.32M -3.32M 3.58M n/a 9.48M -489K 2.38M 4.1M 2.45M -1.05M 6.33M 2.64M 3.82M 624K 4.31M 4.65M 3.48M -329K
Financial Cash Flow
-298.97M -3.32M -246.41M 18.56M 9.48M -489K -249.92M 4.1M 2.45M -164.61M 6.33M -12.4M 367.82M 624K -156.01M -60.07M -44.76M 338.7M
Net Cash Flow
-114.47M 60.48M -38.47M -33.55M 23.24M 46.26M -155.86M 53.06M 124.28M -137.81M 87.04M 56.23M -26.9M -884K -372.96M 44.72M -52.48M 351.75M
Free Cash Flow
98.15M 153.27M 175.41M 113.86M 53.21M 125.88M 99.76M 129.47M 68.47M 75.59M 80.11M 68.63M 39.26M 47.31M 82.36M 121.24M 36.36M 58.03M